Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.
about
GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family.The dawn of vaccines for cancer prevention.Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged ≥50 Years.Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.Optimizing T Cell Expansion in a Hollow-Fiber Bioreactor.Multiple Antigen Stimulating Cellular Therapy (MASCT) For Hepatocellular Carcinoma After Curative Treatment: A Retrospective Study.
P2860
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@ast
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@en
type
label
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@ast
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@en
prefLabel
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@ast
Twelve-year survival and immun ...... -vaccinated melanoma patients.
@en
P2093
P2860
P1433
P1476
Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients
@en
P2093
Beatrice Schuler-Thurner
Erwin Schultz
Erwin Strasser
Gerold Schuler
Ina Haendle
Karl Sotlar
Lucie Heinzerling
Michael Erdmann
Peter Dankerl
Pierre Coulie
P2860
P356
10.1172/JCI.INSIGHT.91438
P577
2017-04-20T00:00:00Z